OSU Navigation Bar

Jill Hollway, M.A.

Jill Hollway
IDD Psychology

Education

Doctoral Candidate in Psychology; Specializing in Pharmacology and Psychosocial treatments; Department of Psychology, Intellectual and Developmental Disabilities Program; The Ohio State University; Dissertation: Examining predictors of sleep disturbance in children with autism spectrum disorders (ASDs).

Master of Arts, Applied Behavior Analysis; Department of Special Education; The Ohio State University, 2004.

Bachelor of Arts (Honors); Psychology, Ohio Wesleyan University, 1998.

Research Interests

Research interests include intervention studies (pharmacological and psychosocial) targeting sleep disturbance and disruptive behavior in children with developmental disabilities. Current activities include Parent Trainer for the NIH-funded Children with Hyperactivity and Autism Research Treatment study (CHARTS). Other responsibilities include blinded clinician, psychometrician, and study monitor for the Research Unit in Pediatric Psychopharmacology (RUPP) at The Ohio State University Nisonger Center.

Grant & Fellowship Awards

August 2009: Nisonger Center Trainee Research Fund, $3730.00. Study of salivary cortisol and its association with anxiety and sleep disturbance in children with autism spectrum disorders (ASDs).

Publications

Arnold, L.E., Aman, M.G., Hollway, J.A., Hurt, E., Bates, B., Li, X., Farmer, C., Anand, R., Thompson, S., Ramadan, Y., &Williams, C. (Under review), Neuronal nicotinic acetylcholine receptor modulation in the treatment of autism: Pilot trial of mecamylamine. Journal of Child & Adolescent Psychopharmacology.

Hollway, J.A., & Aman, M.G. (In press). Characterizing sleep disturbance in children with Pervasive Developmental Disorders: A review of the literature. Research in Developmental Disabilities.

Scahill, L., McDougle, C.J., Aman, M.G., Johnson, C., Handen, B., Bearss, K., Butter, E., Sweizy, N.B., Dziura, J., Arnold, L.E., Stigler, K.A., Sukholdosky, D.E., Lecavalier, L., Pozdol, S.L., Nikolov, R., Ritz, L., Hollway, J.A., Gavaletz, A., Kohn, A.E., Koenig, K., Grinnon, S., Mulick, J.A., Yu, S., & Vitiello, B.(In press). Effects of risperidone and parent training on adaptive functioning in children with a pervasive developmental disorder and serious behavior problems. Journal of the American Academy of Child and Adolescent Psychiatry.

Hollway, J.A., & Aman, M.G. (2011). Pharmacological treatment of sleep disturbance in developmental disabilities: A review of the literature. Research in Developmental Disabilities 32(3), 939-962.

Aman, M.G., Hollway, J.A., Leone, S., Masty, J., Lindsay, R.L., & Nash, P. (2009). Effects of risperidone on cognitive-motor performance in chronically medicated children. Research in Developmental Disabilities 30, 386-396.

Aman, M.G., McDougle, C.J., Scahill, L., Handen, B., Arnold, LE., Johnson, C., Stigler, KA., Bearss, K., Butter, E., Swiezy, N.B., Sukhodolsky, D.D., Ramadan, Y., Pozdol, S.L., Nikolov, R., Lecavalier, L., Kohn, A.E., Koenig, K., Hollway, J.A., Korzekwa, P., Gavaletz, A., Mulick, J.A., Hall, K.L., Dziura, J., Ritz, L., Trollinger, S., Yu, S., Vitiello, B., Wagner, A., & the Research Units on Pediatric Psychopharmacology Autism Network (2009). Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry 48, 1143-1154.

Aman, M.G., Farmer, C.A., Hollway, J.A., & Arnold, L.E. (2008). Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America (D. Posey & C. McDougle, Guest Editors), 17, 713–738.

Aman, M.G., Hollway, J.A., McDougle, C.J., Scahill, L., Tierney, E., McCracken, J., Arnold, L.E., Vitiello, B., Ritz, L., Gavaletz, A., Cronin, P., Swiezy, N.B., Wheeler, C., Koenig, K., Ghuman, J., & Posey, D.J. (2008). Cognitive effects of risperidone in children with autism and irritable behavior. Journal of Child and Adolescent Psychopharmacology 18, 227-236.

Clark, D.L., Arnold, L.E., Crowl, L., Bozzolo, H., Peruggia, M., Ramadan, Y., Bornstein, R., Hollway, J.A., Thompson, S., Malone, K., Hall, K.L., Shelton, S.B., Bozzolo, D.R., & Cook, A. (2008). Vestibular stimulation for ADHD. Journal of Attention Disorders 11, 599-611.

Arnold, L.E., Amato, A., Bozzolo, H., Hollway, J., Cook, A., Ramadan, Y., Crowl, L., Zhang, D., Thompson, S., Testa, G., Kliewer, V., Wigal, T., McMurnett, K., & Manos, M. (2007). Acetyl-L-Carnitine (ALC) in attention-deficit/hyperactivity disorder: A multi-site, placebo-controlled pilot trial. Journal of Child & Adolescent Psychopharmacology 17, 791-802.

Research Units on Pediatric Psychopharmacology [RUPP] Autism Network (Including J.A. Hollway at OSU site) (2007). Parent training for children with Pervasive Developmental Disorders: A multi-site feasibility trial. Behavior Interventions 22, 179-199.

Lecavalier, L., Aman, M.G., Scahill, L., McDougle, C.J., Vitiello, B., Tierney, E., McCracken, J.T., Arnold, L.E., Ghuman, J.K., Posey, D.J., Koenig, K., Cronin, P., Lofton, R.L., Martin, A., Hollway, J., Kau, A.S., & Lee, L. (2006). The validity of the Autism Diagnostic Interview−Revised. American Journal on Mental Retardation 111,199-215.

Williams, S.K., Scahill L., Vitiello, B., Aman, M.G., Arnold, L.E., McDougle, C.J., McCracken, J.T., Tierney, E., Ritz, L., Posey, D.J., Swiezy N.B., Hollway, J., Cronin, P., Ghuman, J., Wheeler, C., Cicchetti, D., & Sparrow, S. (2006). Risperidone and adaptive behavior in children with autism. Journal of the American Academy of Child and Adolescent Psychiatry 45, 431-439.

Research Units on Pediatric Psychopharmacology Autism Network (Aman, M.G., Arnold, L.E., Lindsay, R., Nash, P., Hollway, J., McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., McDougle, C.J., Posey, D., Swiezy, N., Kohn, A., Scahill L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N.M., & Grados, M. (2005). Risperidone treatment of autistic disorder: Longer term benefits and blinded discontinuation after six months. American Journal of Psychiatry 162, 1361-1369.

Arnold, L.E., Bozzolo, H., Hollway, J., Cook, A., DiSilvestro, R., Bozzolo, D., Crowl, L., Ramadan, Y., & Williams, C. (2005). Serum zinc correlates with parent/teacher-rated inattention in children with attention-deficit/hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology 15, 628-636.

McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E., Davies, M., Arnold, L.E., Posey, D.J., Martin, A., Ghuman, J.K., Shah, B., Chuang, S.Z., Swiezy, N.B., Gonzalez, N.M., Hollway, J., Koenig, K., McGough, J., Ritz, L., & Vitiello, B. (2005). Risperidone for the core symptom domains of autism:  Results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology. American Journal of Psychiatry 162, 1142-1148.

Arnold, L.E., Vitiello, B., McDougle, C.J., Scahill, L., Shah, B., Gonzalez, N.M., Chuang, S., Davies, M., Hollway, J.A., Aman, M.G., Cronin, P., Koenig K., Kohn, A.E., McMahon, D.J., & Tierney, E. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child & Adolescent Psychiatry 42, 1443-1450.

Research Units on Pediatric Psychopharmacology Autism Network (McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M.G., Arnold, L.E., Lindsay, R.L., Nash, P., Hollway, J., McDougle, C.J., Posey, D., Swiezy, N., Kohn A., Scahill, L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N. M., Grados, M., Vitiello, B., Ritz, L., Davies, M., Robinson, J., & McMahon, D.) (2002). A double-blind, placebo-controlled trial of risperidone in children with autistic disorder. The New England Journal of Medicine 347, 314-321.

Posters/Presentations

Aman, M.G., Arnold, L.E., & Hollway, J.A. (Sept. 2009). What’s Up with RUPP? Paper presented at National Autism and Developmental Disabilities Conference, Columbus, Ohio.

Kettering, T., Farmer, C., Snow, A., & Hollway, J. (2007, August). Treating autism? Particularly bad fads. In J. Mulick (Chair), Outrageous developmental disabilities treatments: Findings from a graduate seminar. Symposium conducted at the meeting of the American Psychological Association, San Francisco, Calif.

Arnold, L.E., DiSilvestro, R., Bozzolo, D.R., Crowl, L., Fernandez, S., Bozzolo, H., Aman, M.G., & Hollway, J.A. (2007, October). Zinc for ADHD: Interim analysis of a double-blind trial. Poster session at the 54th Annual Meeting of American Academy of Child and Adolescent Psychiatry. Sheraton Boston Hotel, Boston, Mass.

Arnold, L.E., Hollway, J.A., Bozzolo, H., DiSilvestro, R.A., Bozzolo, D.R., Crowl, L., Ramadan, Y., & Williams, C. (2005, June). Zinc in Attention Deficit Hyperactivity Disorder: Correlation with Inattention. Poster session at the 12th biannual scientific meeting of International Society for Research in Child & Adolescent Psychopathology. Roosevelt Hotel, New York, N.Y.

Hollway, J.A., Gardner, R., & Hessler, T. L. (2004, March). Fostering Behavioral Momentum in the Home: Parents as Behavioral Change Agents and the Implications for Families of Children with Autism. Paper presented at the Behavior Analysis Association of Michigan Conference – Eastern Michigan University.

Hollway, J.A., Gardner, R., & Hessler, T. L. (2004, May). Fostering Behavioral Momentum in the Home: Parents as Behavioral Change Agents and the Implications for Families of Children with Autism. Paper presented at the Association for Behavior Analysis Conference, Boston, Mass.

Hollway, J.A. (2003, October). The Effects of Risperidone in Children with Autism. Paper presented at the Autism Society of Ohio Bi-Annual State Conference, Perrysburg, Ohio.